It appears that Tyme Technologies insiders own 31% of the company, worth about US$57m. We usually like to see fairly high levels of insider ownership. I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. Since the selling really does outweigh the buying, we'd say that these transactions may suggest that some insiders feel the company has been fully valued in recent months. On the other hand we note Acting Chief Medical Officer Jan Van Tornout bought US$1.1k worth of shares. In total, insider Michael Demurjian sold US$302k worth of shares in that time. There was substantially more insider selling, than buying, of Tyme Technologies shares over the last three months. Tyme Technologies Insiders Are Selling The Stock
#TYME STOCK NEWS FREE#
If you want to know exactly who sold, for how much, and when, simply click on the graph below! NasdaqCM:TYME Insider Trading Volume September 14th 2021įor those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket. The chart below shows insider transactions (by companies and individuals) over the last year. However, we do note that the average sale price was significantly higher than the current share price (which is US$1.05). Insider selling doesn't make us excited to buy. The average sell price was around US$1.35. Over the last year we saw more insider selling of Tyme Technologies shares, than buying. On December 22, 2021, the Company received notice from The Nasdaq Stock Market ('Nasdaq') that the closing bid price for our common stock had been below 1. So it may not shed much light on insider confidence at current levels. The silver lining is that this sell-down took place above the latest price (US$1.05). While insider selling is a negative, to us, it is more negative if the shares are sold at a lower price. In the last twelve months, the biggest single sale by an insider was when the Co-Founder, Steven Hoffman, sold US$613k worth of shares at a price of US$1.27 per share.
#TYME STOCK NEWS FULL#
TYME lost -$0.18 per share the over the last 12 months.Ĭlick Here to get the full Stock Report for Tyme Technologies Inc stock.The Last 12 Months Of Insider Transactions At Tyme Technologies Over the past year the S&P 500 is higher by 33.10% while TYME is lower by -2.91%. TYME is lower by -$0.01 from the previous closing price of $1.02 on volume of 106,645 shares. Tyme Technologies Inc (TYME) stock is down -1.47% while the S&P 500 is higher by 0.22% as of 10:13 AM on Tuesday, Sep 21. Syros expects to issue approximately 74.3 million shares of its common stock to TYME stockholders to acquire TYME's expected net cash at closing and TYME.
What's Happening With Tyme Technologies Inc Stock Today? Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. This allows you to find the best stocks available in the healthcare sector with relative ease. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. A score of 18 would rank higher than 18 percent of all stocks. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. There are thousands of options and it can be confusing on what actually constitutes a great value. tyme Joey Falcone Strategy: Joined 1/2020 0 Following 0 Followers 2 Posts 269 Liked 8 Watchlist Portfolio, a newsletter by Stocktwits. Not an offer or recommendation by Stocktwits.
Searching for the best stocks to invest in can be difficult. Joey Falcone (tyme) Stocktwits 3rd Party Ad. See Full TYME Report What do These Ratings Mean?
0 kommentar(er)
